ASLAN Pharmaceuticals Ltd - ADR

NASDAQ:ASLN   3:59:40 PM EDT
0.50
0.00 (-0.42%)
Other Pre-Announcement

Aslan Pharma Begins Scientific Collaboration To Investigate Il-13 Receptor Signaling In Atopic Dermatitis

Published: 06/07/2022 11:20 GMT
ASLAN Pharmaceuticals Ltd - ADR (ASLN) - Aslan Pharmaceuticals Initiates Scientific Collaboration to Investigate the Distinct Role of Il-13 Receptor Signaling in Atopic Dermatitis.
Aslan Pharmaceuticals Ltd - Initial Findings From Collaboration Will Be Disclosed for Presentation During Second Half of 2022.